Company: HCTI
Filing Date: 2025-09-30
Form Type: PRE 14A
Source: 0001213900-25-093966
Chunk: 11

Company: Healthcare Triangle, Inc.
Filing Date: 2025-09-30
Form: PRE 14A
Chunk 11
---
 conduct and ethics,
each of our directors and employees is required to report suspected or actual violations to the extent permitted by law. In addition,
we have adopted separate procedures concerning the receipt and investigations of complaints relating to accounting or audit matters.
These procedures have been adopted by the Board of Directors and are administered by our audit committee.

A current copy of our code of business conduct
and ethics is posted on the Governance section of our website, which is located at https://www.healthcaretriangle.com/investors/governence/policies.

Policy on Trading, Pledging and Hedging of Company Stock

Certain transactions in our securities (such
as purchases and sales of publicly traded put and call options, and short sales) create a heightened compliance risk or could create
the appearance of misalignment between management and stockholders. In addition, securities held in a margin account or pledged as collateral
may be sold without consent if the owner fails to meet a margin call or defaults on the loan, thus creating the risk that a sale may
occur at a time when an officer or director is aware of material, non-public information or otherwise is not permitted to trade in Company
securities. Our insider trading policy expressly prohibits short term trading (within six months), short sales and, without prior approval,
purchases or sales of puts, calls or other derivative securities of the or other hedging transactions. In addition, our insider trading
policy expressly requires prior approval from our compliance officer if any of our executive officers, directors and specified other
employees and their respective affiliates wish to borrow against company securities held in a margin account, or, pledging our securities
as collateral for a loan.

Independence of the Board of Directors

Our Board of Directors has determined that Messrs.
Mr. Rosa, Mr. McClurg, and Mr. Bhuiyan satisfy the requirement for independence set out in Nasdaq Rule 5605(b)(1) and that each of these
directors has no material relationship with us (other than being a director and/or a stockholder). In making its independence determinations,
the Board of Directors sought to identify and analyze all of the facts and circumstances relating to any relationship between a director,
his or her immediate family or affiliates and our company and our affiliates and did not rely on categorical standards other than those
contained in the Nasdaq rule referenced above. A majority of the members of our Board of Directors are independent under Nasdaq rule.

<div align='center'>7</div>

Identifying and Evaluating Director Nom